Coupling Factors in Macromolecular Type-IV Secretion Machineries

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|13|1551-1565

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.13, 2004-05, pp. : 1551-1565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IV exenatide preserves glucose-dependent insulin secretion

By  

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice

By Ahren B.   Holst J.J.   Martensson H.   Balkan B.  

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 239-245

Elsevier

Access to resources Recommend Favorite

Cotrimoxazole: Type IV hypersensitivity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

The Type III secretion system of Gram-negative bacteria: a potential therapeutic target?

By Müller Simone   Feldman Mario F   Cornelis Guy R  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 327-339

Informa Healthcare

Access to resources Recommend Favorite

Targeting Type VII/ESX Secretion Systems for Development of Novel Antimycobacterial Drugs

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4346-4356

Bentham Science Publishers

Access to resources Recommend Favorite